Core Insights - Innovative surgical robot company 康诺思腾 has completed a new funding round of approximately $200 million, exceeding its target [1] - The funds will primarily be used to accelerate commercialization efforts and support the development and clinical registration of next-generation products [1] - The financing round included investments from Hong Kong Investment Management Company, a global strategic investor, and a top global sovereign wealth fund, along with continued support from investors such as启明创投, 道合投资, 高榕创投, and 险峰 [1]